Rofecoxib: a selective COX-2 inhibitor New drugs and disease management 12 February 2013 Pages: 1 - 5
Refining muromonab CD3 administration can reduce adverse effects New drugs and disease management 12 February 2013 Pages: 5 - 7
Time is of the essence when treating acute ischaemic stroke New drugs and disease management 12 February 2013 Pages: 7 - 10
Chemoprotectants ameliorate chemotherapy-associated toxicity at specific sites New drugs and disease management 12 February 2013 Pages: 11 - 13
Visual field defects with vigabatrin: an unforeseen problem? Drug reactions and interactions 12 February 2013 Pages: 14 - 16